Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amgen Inc ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 USA

P: 805-447-1000 F: 805-447-1010

Description:

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

Key Statistics

Overview:

Market Capitalization, $K 121,315,904
Shares Outstanding, K 567,852
Annual Sales, $ 25,424 M
Annual Net Income, $ 7,264 M
Last Quarter Sales, $ 6,526 M
Last Quarter Net Income, $ 464,000 K
60-Month Beta 0.68
% of Insider Shareholders 0.36%
% of Institutional Shareholders 74.73%
Float, K 565,808
% Float 99.64%

Growth:

1-Year Return -11.78%
3-Year Return 3.06%
5-Year Return 28.07%
5-Year Revenue Growth 17.37%
5-Year Earnings Growth 59.92%
5-Year Dividend Growth 102.53%

Per-Share Information:

Most Recent Earnings 4.38 on 08/03/21
Next Earnings Date 10/27/21
Earnings Per Share ttm 16.26
EPS Growth vs. Prev Qtr 18.38%
EPS Growth vs. Prev Year 3.06%
Annual Dividend Rate, $ 7.04
Annual Dividend Yield 3.18%
Most Recent Dividend 1.760 on 08/16/21
Next Ex-Dividends Date 08/16/21
Dividend Payable Date 09/08/21
Dividend Payout Ratio 40.89%
Most Recent Split 2-1 on 11/22/99

AMGN Ratios

Ratio
Price/Earnings ttm 13.24
Price/Earnings forward 14.80
Price/Earnings to Growth 1.64
Return-on-Equity % 99.85%
Return-on-Assets % 15.16%
Profit Margin % 28.57
Net Margin % 29.71
Debt/Equity 3.34
Price/Sales 4.81
Price/Cash Flow 9.84
Price/Book 15.59
Book Value/Share 14.52
Interest Coverage 7.44

AMGN Dividends

Date Value
08/16/21 $1.7600
05/14/21 $1.7600
02/11/21 $1.7600
11/13/20 $1.6000
08/14/20 $1.6000
05/15/20 $1.6000
02/13/20 $1.6000
11/14/19 $1.4500
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar